Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies Statistics

Total Valuation

TSHA has a market cap or net worth of $395.65 million. The enterprise value is $320.18 million.

Market Cap	395.65M
Enterprise Value	320.18M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TSHA has 205.00 million shares outstanding. The number of shares has increased by 115.41% in one year.

Current Share Class	205.00M
Shares Outstanding	205.00M
Shares Change (YoY)	+115.41%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	13.98%
Owned by Institutions (%)	63.98%
Float	127.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	57.93
Forward PS	57.72
PB Ratio	5.53
P/TBV Ratio	5.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	38.42
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.42, with a Debt / Equity ratio of 0.89.

Current Ratio	5.42
Quick Ratio	5.30
Debt / Equity	0.89
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-849.23

Financial Efficiency

Return on equity (ROE) is -121.94% and return on invested capital (ROIC) is -39.94%.

Return on Equity (ROE)	-121.94%
Return on Assets (ROA)	-32.51%
Return on Invested Capital (ROIC)	-39.94%
Return on Capital Employed (ROCE)	-64.58%
Revenue Per Employee	$114,151
Profits Per Employee	-$1.22M
Employee Count	73
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.12% in the last 52 weeks. The beta is 0.89, so TSHA's price volatility has been lower than the market average.

Beta (5Y)	0.89
52-Week Price Change	-39.12%
50-Day Moving Average	1.65
200-Day Moving Average	2.06
Relative Strength Index (RSI)	64.48
Average Volume (20 Days)	1,712,055

Short Selling Information

The latest short interest is 25.25 million, so 12.32% of the outstanding shares have been sold short.

Short Interest	25.25M
Short Previous Month	25.53M
Short % of Shares Out	12.32%
Short % of Float	19.77%
Short Ratio (days to cover)	15.72

Income Statement

In the last 12 months, TSHA had revenue of $8.33 million and -$89.30 million in losses. Loss per share was -$0.36.

Revenue	8.33M
Gross Profit	8.33M
Operating Income	-86.62M
Pretax Income	-118.01M
Net Income	-89.30M
EBITDA	-85.38M
EBIT	-86.62M
Loss Per Share	-$0.36

Balance Sheet

The company has $139.04 million in cash and $63.56 million in debt, giving a net cash position of $75.48 million or $0.37 per share.

Cash & Cash Equivalents	139.04M
Total Debt	63.56M
Net Cash	75.48M
Net Cash Per Share	$0.37
Equity (Book Value)	71.53M
Book Value Per Share	0.35
Working Capital	115.90M

Cash Flow

In the last 12 months, operating cash flow was -$81.23 million and capital expenditures -$374,000, giving a free cash flow of -$81.60 million.

Operating Cash Flow	-81.23M
Capital Expenditures	-374,000
Free Cash Flow	-81.60M
FCF Per Share	-$0.40

Margins

Gross Margin	100.00%
Operating Margin	-1,039.49%
Pretax Margin	-1,071.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSHA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-115.41%
Shareholder Yield	n/a
Earnings Yield	-22.57%
FCF Yield	-20.62%

Analyst Forecast

The average price target for TSHA is $6.63, which is 243.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.63
Price Target Difference	243.52%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	120.30%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSHA has an Altman Z-Score of -3.07 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.07
Piotroski F-Score	2